CCM
PFE icon

Chiron Capital Management’s Pfizer PFE Stock Holding History

Chiron Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
67,214
+8,088
+14% +$212K 1.45% 15
2026
Q1 		$1.66M Buy
+59,126
New +$1.57M 1.7% 12
2025
Q3 		$1.85M Sell
72,684
-388
-0.5% -$9.58K 1.59% 16
2025
Q2 		$1.77M Sell
73,072
-1,963
-3% -$45.8K 1.54% 16
2025
Q1 		$1.9M Buy
75,035
+14,740
+24% +$386K 1.73% 10
2024
Q4 		$1.6M Sell
60,295
-7,975
-12% -$216K 1.51% 11
2024
Q3 		$1.98M Sell
68,270
-1,716
-2% -$50.1K 1.75% 9
2024
Q2 		$1.96M Buy
69,986
+526
+0.8% +$14.5K 1.87% 8
2024
Q1 		$1.93M Buy
69,460
+28,079
+68% +$779K 1.75% 5
2023
Q4 		$1.19M Sell
41,381
-11,448
-22% -$346K 1.04% 24
2023
Q3 		$1.75M Buy
52,829
+32,426
+159% +$1.15M 1.51% 10
2023
Q2 		$748K Buy
20,403
+10,000
+96% +$389K 0.59% 39
2023
Q1 		$424K Buy
10,403
+2,248
+28% +$97.1K 0.3% 69
2022
Q4 		$418K Sell
8,155
-1,100
-12% -$52.7K 0.29% 65
2022
Q3 		$405K Buy
9,255
+1,245
+16% +$60.5K 0.27% 73
2022
Q2 		$420K Sell
8,010
-24,022
-75% -$1.22M 0.27% 74
2022
Q1 		$1.66M Sell
32,032
-26,643
-45% -$1.38M 1.05% 13
2021
Q4 		$3.46M Sell
58,675
-5,896
-9% -$292K 2.5% 4
2021
Q3 		$2.78M Sell
64,571
-69,938
-52% -$3.1M 2.03% 5
2021
Q2 		$5.27M Sell
134,509
-19,320
-13% -$751K 4.39% 3
2021
Q1 		$5.57M Buy
153,829
+90,843
+144% +$3.23M 4.73% 3
2020
Q4 		$2.32M Sell
62,986
-18,305
-23% -$671K 1.91% 7
2020
Q3 		$2.83M Buy
+81,291
New +$2.85M 2.28% 5

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Chiron Capital Management's PFE Position: Q2 2026 in Review

Chiron Capital Management increased its Pfizer (PFE) stake by 14% in Q2 2026, buying an estimated $212K and bringing the position to 67,214 shares worth $1.62M. The position accounts for 1.45% of the portfolio, ranked #15.

Chiron Capital Management first reported a position in PFE in Q3 2020 and has held it in 23 quarters since. The position peaked at $5.57M in Q1 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Chiron Capital Management held 67,214 shares of Pfizer worth $1.62M as of Q2 2026.
  • Chiron Capital Management bought 8,088 Pfizer shares in Q2 2026, an estimated $212K.
  • Pfizer made up 1.45% of Chiron Capital Management's portfolio in Q2 2026, its #15 holding.
  • Chiron Capital Management first reported a position in Pfizer in Q3 2020 and has held it in 23 quarters since.
  • Chiron Capital Management's Pfizer position peaked at $5.57M in Q1 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.